Glonghui, May 9 | According to the latest equity disclosure data on the Stock Exchange, on May 2, 2024, Sinopharm Holdings (01099.HK) was reduced by JPMorgan Chase & Co. from a good position of 1.171 million shares at an average price of HK$19.4312 per share, involving an investment of about HK$22.754 million.
After reducing its holdings, JPMorgan Chase & Co.'s latest number of open positions was 798.571 million shares, and the holding ratio dropped from 6.03% to 5.95%.
